Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis

Drug and Alcohol Dependence

Volumn 165, Issue , 2016, Pages 1-8

  Chang, Hsien Yen ^a   Lyapustina, Tatyana ^a   Rutkow, Lainie ^a   Daubresse, Matthew ^a   Richey, Matt ^b   Faul, Mark ^c   Stuart, Elizabeth A ^a   Alexander, G Caleb ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b ST OLAF COLLEGE   (United States)

^c NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

High risk opioid prescribing; Pill mill law; Prescription drug abuse; Prescription drug monitoring program; Time series analysis

Indexed keywords

ARTICLE; DRUG SURVEILLANCE PROGRAM; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HIGH RISK POPULATION; HUMAN; MORBIDITY; MORTALITY; OPIATE ADDICTION; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; PUBLIC HEALTH; SENSITIVITY ANALYSIS; UNITED STATES; CLINICAL PRACTICE; DRUG LEGISLATION; EPIDEMIOLOGY; FACTUAL DATABASE; FLORIDA; GEORGIA; POSTMARKETING SURVEILLANCE; STATISTICS AND NUMERICAL DATA; TRENDS;

NARCOTIC ANALGESIC AGENT;

ANALGESICS, OPIOID; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FLORIDA; GEORGIA; HUMANS; INTERRUPTED TIME SERIES ANALYSIS; LEGISLATION, DRUG; PRACTICE PATTERNS, PHYSICIANS'; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 84976505728     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.04.033     Document Type: Article

References (29)

1. Blumenschein, K., Fink, J., Freeman, P., Kirsh, K., Steinke, D., Talbert, J., Independent Evaluation of the Impact and Effectiveness of the Kentucky All Schedule Prescription Electronic Reporting Program (KASPER)., 2010, Frankfort, Kentucky.
2. Calcaterra, S., Glanz, J., Binswanger, I.A., National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 131 (2013), 263–270.
3. Cepeda, M.S., Fife, D., Berlin, J.A., Mastrogiovanni, G., Yuan, Y., Characteristics of prescribers whose patients shop for opioids: results from a cohort study. J. Opioid Manage. 8 (2012), 285–291.
4. Chang, H.Y., Daubresse, M., Kruszewski, S.P., Alexander, G.C., Prevalence and treatment of pain in EDs in the United States, 2000–2010. Am. J. Emerg. Med. 32 (2014), 421–431.
5. Chou, R., Turner, J.A., Devine, E.B., Hansen, R.N., Sullivan, S.D., Blazina, I., Dana, T., Bougatsos, C., Deyo, R.A., The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann. Intern. Med. 162 (2015), 276–286.
6. Daubresse, M., Chang, H.Y., Yu, Y., Viswanathan, S., Shah, N.D., Stafford, R.S., Kruszewski, S.P., Alexander, G.C., Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000–2010. Med. Care 51 (2013), 870–878.
7. Delcher, C., Wagenaar, A.C., Goldberger, B.A., Cook, R.L., Maldonado-Molina, M.M., Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program. Drug Alcohol Depend. 150 (2015), 63–68.
8. Dhalla, I.A., Mamdani, M.M., Gomes, T., Juurlink, D.N., Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario. Can. Fam. Phys. 57 (2011), e92–96.
9. Dhalla, I.A., Persaud, N., Juurlink, D.N., Facing up to the prescription opioid crisis. BMJ, 343, 2011, d5142.
10. Florida Office of the Attorney General. 2015. Florida's Prescription Drug Diversion and Abuse Roadmap. 2012–2015.
11. Franklin, G., Sabel, J., Jones, C.M., Mai, J., Baumgartner, C., Banta-Green, C.J., Neven, D., Tauben, D.J., A comprehensive approach to address the prescription opioid epidemic in Washington State: milestones and lessons learned. Am. J. Public Health 105 (2015), 463–469.
12. Giraudon, I., Lowitz, K., Dargan, P.I., Wood, D.M., Dart, R.C., Prescription opioid abuse in the UK. Br. J. Clin. Pharmacol. 76 (2013), 823–824.
13. Gwira Baumblatt, J.A., Wiedeman, C., Dunn, J.R., Schaffner, W., Paulozzi, L.J., Jones, T.F., High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern. Med. 174 (2014), 796–801.
14. Haegerich, T.M., Paulozzi, L.J., Manns, B.J., Jones, C.M., What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend. 145 (2014), 34–47.
15. Johnson, H., Paulozzi, L., Porucznik, C., Mack, K., Herter, B., Decline in drug overdose deaths after state policy changes—Florida, 2010–2012. MMWR 63 (2014), 569–574.
16. Kolodny, A., Courtwright, D.T., Hwang, C.S., Kreiner, P., Eadie, J.L., Clark, T.W., Alexander, G.C., The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu. Rev. Public Health 36 (2015), 559–574.
17. Lyapustina, T., Rutkow, L., Chang, H.Y., Daubresse, M., Ramji, A.F., Faul, M., Stuart, E.A., Alexander, G.C., Effect of a pill mill law on opioid prescribing and: the case of Texas. Drug Alcohol Depend. 159 (2016), 190–197.
18. Nuckols, T.K., Anderson, L., Popescu, I., Diamant, A.L., Doyle, B., Di Capua, P., Chou, R., Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann. Intern. Med. 160 (2014), 38–47.
19. Paulozzi, L.J., Kilbourne, E.M., Shah, N.G., Nolte, K.B., Desai, H.A., Landen, M.G., Harvey, W., Loring, L.D., A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 13 (2012), 87–95.
20. Paulozzi, L.J., Mack, K.A., Hockenberry, J.M., Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines— United States, 2012. MMWR 63 (2014), 563–568.
21. Rutkow, L., Chang, H.Y., Daubresse, M., Webster, D.W., Stuart, E.A., Alexander, G.C., Effect of florida's prescription drug monitoring program and pill mill laws on opioid prescribing and use. JAMA Intern. Med. 175 (2015), 1642–1649.
22. Sauber-Schatz, E.K., Mack, K.A., Diekman, S.T., Paulozzi, L.J., Associations between pain clinic density and distributions of opioid pain relievers drug-related deaths, hospitalizations, emergency department visits, and neonatal abstinence syndrome in Florida. Drug Alcohol Depend. 133 (2013), 161–166.
23. Stannard, C., Opioids in the UK: what's the problem?. BMJ, 347, 2013, f5108.
24. Stewart, G., Basler, M.H., Wanted: national regulatory monitoring system for long term opioid prescription. BMJ, 347, 2013, f5586.
25. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. 2013 http://archive.samhsa.gov/data/2k13/DAWN127/sr127-DAWN-highlights.htm.
26. Swedlow, A., Ireland, J., Johnson, G., Prescribing Patterns of Schedule II Opioids Part 2: Fentanyl Prescriptions in California Workers' Compensation. 2011 http://www.cwci.org/research.html.
27. United States Department of Health and Human Services, Centers for Disease Control and Prevention, Menu of Pain Management Clinic Regulation. 2012 http://www.cdc.gov/phlp/docs/menu-pmcr.pdf.
28. United States Department of Health and Human Services, Centers for Disease Control and Prevention, National Vital Statistics System Mortality Data. 2015 http://www.cdc.gov/nchs/deaths.htm.
29. United States Department of Justice, Drug Enforcement Administration, State Prescription Drug Monitoring Programs: Questions and Answers. 2011 http://www.deadiversion.usdoj.gov/faq/rx_monitor.htm.